Browsing by Author Ito, Masaoki
Showing results 1 to 4 of 4
| Issue Date | Title | Author(s) |
|---|---|---|
| 1-Aug-2019 | Hsp90 inhibitors enhance the antitumoral effect of osimertinib in parental and osimertinib-resistant non-small cell lung cancer cell lines | Codony Servat, Jordi; Viteri, Santiago; Codony Servat, Carles; Ito, Masaoki; Bracht, Jillian Willhelmina Paulina; Berenguer, Jordi; Chaib, Imane; Molina Vila, Miguel Angel; Karachaliou, Niki; Rosell, Rafael |
| 12-Jun-2024 | KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combination | Rosell, Rafael; Jantus Lewintre, Eloisa; Cao, Peng; Cai, Xueting; Xing, Baojuan; Ito, Masaoki; Gómez Vázquez, José Luis; Marco Jordán, Mireia; Calabuig Fariñas, Silvia; Cardona, Andrés Felipe; Codony Servat, Jordi; González, Jessica; València Clua, Kevin; Aguilar, Andrés; Pedraz Valdunciel, Carlos; Dantes, Zahra; Jain, Anisha; Chandan, S.; Molina Vila, Miguel Ángel; Arrieta, Óscar; Ferrero, Macarena; Camps, Carlos; González Cao, María |
| 10-Apr-2023 | Macrophage Cd5l is a target for cancer immunotherapy | Sanchez Moral, Lidia; Paul, Tony; Martori, Clara; Font-Díaz, Joan; Sanjurjo, Lucía; Aran, Gemma; Téllez, Érica; Blanco, Julià; Carrillo, Jorge; Ito, Masaoki; Tuttolomondo, Martina; Ditzel, Henrik J.; Fumagalli, Caterina; Tapia, Gustavo; Sidorova, Julia; Masnou, Helena; Fernández Sanmartín, Marco-Antonio; Lozano Salvatella, Juan José; Vilaplana, Cristina; Rodriguez Cortés, Alhelí; Armengol, Carolina; Valledor Fernández, Annabel; Kremer, Leonor; Sarrias, Maria Rosa |
| 28-Oct-2019 | Targeting PKC iota-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma | Ito, Masaoki; Codony Servat, Carles; Codony Servat, Jordi; Lligé, David; Chaib, Imane; Sun, Xiaoyan; Miao, Jing; Sun, Rongwei; Cai, Xueting; Verlicchi, Alberto; Okada, Morihito; Molina Vila, Miguel Angel; Karachaliou, Niki; Cao, Peng; Rosell, Rafael |